TickerFacts.

Castle Biosciences Inc (CSTL): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$273.20M
Year ended 2025-12-31
$276.03M
Trailing 12 months to 2026-06-30
+37.5%
3-year compound annual growth
+38.8%
5-year compound annual growth
2018-12-31: $17.49M2019-12-31: $44.55M2020-12-31: $52.96M2021-12-31: $78.26M2022-12-31: $105.03M2023-12-31: $174.81M2024-12-31: $271.86M2025-12-31: $273.20M$273.20M
2018-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$273.20M+0.5%2026-02-26, From 2025-01-01
2024-12-31$271.86M+55.5%2026-02-26, From 2024-01-01
2023-12-31$174.81M+66.4%2026-02-26, From 2023-01-01
2022-12-31$105.03M+34.2%2025-02-27, From 2022-01-01
2021-12-31$78.26M+47.8%2023-02-28, From 2021-01-01
2020-12-31$52.96M+18.9%2021-03-11, From 2020-01-01
2019-12-31$44.55M+154.8%2021-03-11, From 2019-01-01
2018-12-31$17.49Mn/a2020-03-10, From 2018-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Castle Biosciences Inc (CSTL)2025-12-31$273.20M+0.5%
Fulgent Genetics, Inc. (FLGT)2025-12-31$130.88M+22.1%
BillionToOne, Inc. (BLLN)2025-12-31$208.46M+157.6%
Veracyte, Inc. (VCYT)2025-12-31$362.53M+21.6%
Guardant Health, Inc. (GH)2025-12-31$633.01M+40.9%
Personalis, Inc. (PSNL)2025-12-31$15.78M-41.2%
Exagen Inc. (XGN)2025-12-31$38.80M+17.2%
American Shared Hospital Services (AMS)2025-12-31$5.06M-44.9%
Quest Diagnostics Inc (DGX)2025-12-31$3.67B+13.0%

Compare CSTL, FLGT, BLLN, VCYT side by side · Screen every company in Services-Medical Laboratories ↗